Monitoring patients for bladder neoplasms: What can be expected of urinary cytology consultations in clinical practice

Urology

Volumn 54, Issue 1, 1999, Pages 62-66

  Malik, Shazli N ^a   Murphy, William M ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER GRADING; CLINICAL PRACTICE; CYTOPATHOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OBSERVER VARIATION; PATIENT MONITORING; PRIORITY JOURNAL; URINE CYTOLOGY;

EID: 0033169111     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00065-5     Document Type: Article

References (14)

1. Rife CC, Farrow GM, and Utz DG: Urine cytology of transitional cell neoplasms. Urol Clin North Am 6: 599-612, 1979.
2. de Voogt HJ, and Wielenga G: Clinical aspects of urinary cytology. Acta Cytol 16: 349-351, 1972.
3. Koss LG, Deitch D, Ramanathan R, et al: Diagnostic value of cytology of voided urine. Acta Cytol 29: 810-816, 1985.
4. Zein T, Wajsman Z, Englander L, et al: Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa. J Urol 132: 670-671, 1984.
5. Wiener HG, Vooijs GP, and van't Hof-Grootenboer B: Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 37: 163-169, 1993.
6. Murphy WM, Soloway MS, Jukkola AF, et al: Urinary cytology and bladder cancer: the cellular features of transitional cell neoplasms. Cancer 53: 1555-1565, 1984.
7. Raab SS, Slagel DD, Jensen CS, et al: Transitional cell carcinoma: cytologic criteria to improve diagnostic accuracy. Mod Pathol 9: 225-232, 1996.
8. Sarosdy ME, deVere White RW, Soloway MS, et al: Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 154: 379-383, 1995.
9. Johnston B, Morales A, Emerson L, et al: Rapid detec-tion of bladder cancer: a comparative study of point of care tests. J Urol 158: 2098-2101, 1997.
10. Stampfer DS, Carpinito GA, Rodriguez-Villanueva J, et al: Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder. J Urol 159: 394-398, 1998.
11. Steiner G, Schoenberg MP, Linn JF, et al: Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat Med 3: 621-624, 1997.
12. Murphy WM, Beckwith JB, and Farrow GM: Tumors of the Kidney, Bladder and Related Urinary Structures. Atlas of Tumor Pathology, 3rd Series Fascicle. No. 11. Washington, DC, Armed Forces Institute of Pathology, 1994, pp 202-233.
13. Mostofi FK, Sobin LH, and Torloni H: Histological Typing of Urinary Bladder Tumours. International Histological Classification of Tumours, No. 10. Geneva, World Health Organization, 1973.
14. Epstein JI, Amin MB, Reuter VR, et al: The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22: 1435-1448, 1998.